Holding(s) in Company
July 08 2003 - 8:21AM
UK Regulatory
RNS Number:2925N
British Biotech PLC
08 July 2003
SCHEDULE 10
NOTIFICATION OF MAJOR INTERESTS IN SHARES
1. Name of company
British Biotech plc
2. Name of shareholder having a major interest
Amvescap plc
3. Please state whether notification indicates that it is in respect of holding
of the shareholder named in 2 above or in respect of a non-beneficial interest
or in the case of an individual holder if it is a holding of that person's
spouse or children under the age of 18
Notification is in respect of an interest on behalf of discretionary managed
clients of Amvescap plc. By virtue of the Companies Act Section 203 Amvescap is
deemed to have the same interest in the shares
4. Name of the registered holder(s) and, if more than one holder, the number of
shares held by each of them
Vidacos Nominees Ltd 9,774,386
HSBC Nominees Ltd 2,517,726
Chase Nominees Ltd 372,389
Bank of New York Nominees Ltd 887,343
Northern Trust Nominees Ltd 178,870
CM Investment Nominees Ltd 1,718
5. Number of shares / amount of stock acquired
3,405,000
6. Percentage of issued class
5.1 per cent
7. Number of shares / amount of stock disposed
n/a
8. Percentage of issued class
n/a
9. Class of security
Ordinary 5p shares
10. Date of transaction
4 July, 2003
11. Date company informed
7 July, 2003
12. Total holding following this notification
13,732,432 shares
13. Total percentage holding of issued class following this notification
20.57 per cent
14. Any additional information
Amvescap advises that its shareholding includes the following notifiable
holdings, both of which are registered in the name of Vidacos Nominees Ltd:
INVESCO Perpetual High Income Fund, which holds 3,000,403 shares (4.49 per
cent), and;
INVESCO Perpetual UK Growth Fund, which holds 2,090,709 shares (3.13 per cent)
15. Name of contact and telephone number for queries
Tony Weir, Finance Director, + 44 1 865 781166
16. Name and signature of authorised company official responsible for making
this notification
Stephen Powers
Date of notification
8 July, 2003
The FSA does not give any express or implied warranty as to the accuracy of this
document or material and does not accept any liability for error or omission.
The FSA is not liable for any damages (including, without limitation, damages
for loss of business or loss of profits) arising in contract, tort or otherwise
from the use of or inability to use this document, or any material contained in
it, or from any action or decision taken as a result of using this document or
any such material.
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLRPMTTMMBMBLJ